ESR1 and major depressive disorder: In the Lipopolysaccharide (LPS) – induced depression model, it was found that E2 or ERα agonist treatment inhibited the activation of NF-γB and reduced the expression of pro-inflammatory cytokines, indicating that NF-γB and downstream inflammatory cytokines were regulated by E2/ERα (96).